as on January 17, 2026 at 2:29 am IST
Day's Low
0.78%
Downside
52 Week's Low
52 Week's High
65.50%
Downside
3.10%
Upside
Check Repare Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$110.8M
EPS (TTM)
-2.11
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.86
Industry PE ratio
-1.7256034482758622
PEG Ratio
0EBITDA
-76.5M
Revenue (TTM)
11.9M
Profit Margin
0.00%
Return On Equity TTM
-49.78%
Track how Repare Therapeutics Inc P/E has moved over time to understand its valuation trends.
Repare Therapeutics Inc in the last 5 years
Lowest (-68.69x)
June 30, 2023
Today (-1.86x)
January 17, 2026
Industry (-1.73x)
January 17, 2026
Highest (-0.40x)
March 31, 2025
Today’s Price to Earnings Ratio: -1.86x
Compare market cap, revenue, PE, and other key metrics of Repare Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $110.8M | -93.78% | -1.86 | 0.00% | |
| BUY | $47.5B | 115.96% | 1238.83 | 1.36% | |
| BUY | $112.5B | 95.68% | 30.87 | 31.35% | |
| NA | $37.4B | NA | 663.31 | 1.38% | |
| BUY | $78.6B | 41.53% | 17.79 | 32.13% |
The Repare Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Repare Therapeutics Inc investment value today
Current value as on today
₹2,06,448
Returns
₹1,06,448
(+106.45%)
Returns from Repare Therapeutics Inc Stock
₹1,01,563 (+101.56%)
Dollar Returns*
₹4,886 (+4.89%)
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Repare Therapeutics Inc. Average target price of $3
Get share price movements and forecasts by analysts on Repare Therapeutics Inc.
What analysts predicted
14%UPSIDE
Target Price
$3
Current Price
$2.58
Analyzed by
13 Analysts
Target
$3.00
Repare Therapeutics Inc target price $3, a slight upside of 14% compared to current price of $2.58. According to 13 analysts rating.
Search interest for Repare Therapeutics Inc Stock has increased by 99% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:99% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 24 December
Wed, 06:19 PM
-Repare Therapeutics agrees to sell RP-3467 to Gilead for up to $30 million, boosting cash balance and shareholder value.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, -53.47M → 11.62M (in $), with an average increase of 10794.3% per quarter
Price Rise
![]()
In the last 3 months, RPTX stock has moved up by 40.4%
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -30.04M → 3.25M (in $), with an average increase of 346.7% per quarter
Best in 1 Year
![]()
In the last 1 year, RPTX has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 26.4% return, outperforming this stock by 106.0%
| Organisation | Repare Therapeutics Inc |
| Headquarters | 7171 Frederick-Banting, Building 2, Montreal, QC, Canada, H4S 1Z9 |
| Industry | Health Technology |
| CEO | Mr. Steve Forte CPA |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Sandra Alves | Senior VP & Chief Accounting Officer |
Mr. Daniel Belanger | Executive Vice President of Human Resources |
Dr. Joseph P. O'Connell M.D. | Executive Vice President of Clinical Development and Medical Affairs |
Mr. Steve Forte CPA | President, CFO, CEO & Director |
Dr. Daniel Durocher Ph.D. | Co-Founder |
Dr. Frank Sicheri Ph.D. | Co-Founder |
Dr. Agnel Sfeir Ph.D. | Co-Founder |
Repare Therapeutics Inc share price today is $2.58 as on at the close of the market. Repare Therapeutics Inc share today touched a day high of $2.58 and a low of $2.56.
Repare Therapeutics Inc share touched a 52 week high of $2.66 on and a 52 week low of $0.89 on . Repare Therapeutics Inc stock price today i.e. is closed at $2.58,which is 3.01% down from its 52 week high and 189.89% up from its 52 week low.
Repare Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Repare Therapeutics Inc (RPTX) shares with as little as ₹90.81 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹908.10 in Repare Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Repare Therapeutics Inc share’s latest price of $2.58 as on January 17, 2026 at 2:29 am IST, you will get 3.8760 shares of Repare Therapeutics Inc. Learn more about
fractional shares .
Repare Therapeutics Inc stock has given -93.78% share price returns and 23.36% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?